Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRecord History now includes a new revision entry for v3.6.6 and drops the previous v3.6.5 from the list. This updates the page’s visible version history to reflect the latest revision entry for the study record.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedNew revision entry v3.6.5 was added to the study record history, and the previous revision v3.6.4 was removed from the history list. This represents an update to the page's version history metadata and does not modify the study data or public content.SummaryDifference0.1%

- Check44 days agoChange DetectedThe record history gains a new revision entry for v3.6.4 and removes the previous v3.6.3 entry, reflecting an update to the page's version history.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision entry (v3.6.3) was added to the record history, and the previous revision (v3.6.2) was removed. This reflects an update to the page's version history.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history. The previous v3.6.0 entry was removed, updating the record's version history.SummaryDifference0.1%

- Check87 days agoChange DetectedThe study record now shows 'No longer looking for participants', indicating enrollment for the trial is closed. The page revision tag was updated from v3.5.5 to v3.6.0, reflecting an updated version of the record.SummaryDifference0.4%

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.